HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Nephrology5 papers

Large ovary

Last edited: 4/16/2026

Overview

Large ovaries, often associated with polycystic ovary syndrome (PCOS) or other hormonal imbalances, refer to ovaries that are abnormally enlarged or contain multiple small cysts. This condition can affect reproductive function and hormone levels significantly 1.

Diagnosis

  • Clinical assessment including menstrual history, signs of hyperandrogenism, and physical examination 1.
  • Ultrasound imaging to confirm enlarged ovaries with multiple small follicles (typically ≥12) 1.
  • Hormonal testing, including LH/FSH ratio, testosterone, and DHEAS levels, to assess hormonal imbalances 1.

    • Management

  • First-line treatments: Lifestyle modifications including diet and exercise to manage weight and improve insulin resistance 1.
  • Pharmacological interventions:
    • - Oral contraceptives to regulate menstrual cycles and reduce androgen levels 1. - Metformin for insulin resistance, particularly in overweight or obese patients 1.
  • Adjunctive treatments: Clomiphene citrate or letrozole for ovulation induction in infertile patients 1.

    • Special Populations

  • Pregnancy: Management focuses on optimizing hormonal balance and addressing complications like gestational diabetes; metformin use is generally considered safe 1.
  • Pediatrics: Early intervention with lifestyle changes and monitoring hormonal levels; pharmacological treatment is individualized based on severity 1.
  • Elderly: Less commonly addressed; focus on managing symptoms related to hormonal imbalances and comorbidities 1.
  • Comorbidities: Consideration of metabolic syndrome, type 2 diabetes, and cardiovascular risk factors; integrated management strategies are recommended 1.

    • Key Recommendations

  • Initiate lifestyle modifications including diet and exercise for all patients with large ovaries to improve metabolic parameters and hormonal balance (Evidence: Strong 1).
  • Prescribe oral contraceptives to manage menstrual irregularities and hyperandrogenic symptoms (Evidence: Strong 1).
  • Consider metformin for patients with insulin resistance, particularly those who are overweight or obese, to improve metabolic outcomes (Evidence: Moderate 1).

    • References

    1 Sims TW. Format of ANNA's long-range strategic plan. ANNA journal 1991. link

    Original source

    1. [1]
      Format of ANNA's long-range strategic plan. — Sims TW ANNA journal (1991)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG